{"Relapse": [0], "to": [1, 22, 24, 83, 93, 109, 159, 162, 165], "anti-HER2": [2], "monoclonal": [3], "antibody": [4], "(mAb)": [5], "therapies,": [6], "such": [7], "as": [8, 36, 72], "trastuzumab": [9, 41, 94, 166], "in": [10, 43, 91, 133], "HER2+": [11, 44, 135, 160], "breast": [12], "cancer": [13], "(BC),": [14], "is": [15, 54, 70], "associated": [16, 56], "with": [17, 57, 120], "residual": [18], "disease": [19], "progression": [20], "due": [21], "resistance": [23, 164], "therapy.": [25], "Here,": [26], "we": [27], "identify": [28], "interferon-\u03b3": [29], "inducible": [30], "protein": [31], "16": [32], "(IFI16)-dependent": [33], "STING": [34, 85], "signaling": [35, 152], "a": [37, 73, 112, 115, 134, 156], "significant": [38], "determinant": [39], "of": [40, 50, 60, 76, 80, 98, 114, 149], "responses": [42, 108], "BC.": [45], "We": [46], "show": [47], "that": [48, 154], "down-regulation": [49], "immune-regulated": [51], "genes": [52], "(IRG)": [53], "specifically": [55], "poor": [58], "survival": [59, 157], "HER2+,": [61], "but": [62], "not": [63], "other": [64], "BC": [65, 136, 161], "subtypes.": [66], "Among": [67], "IRG,": [68], "IFI16": [69], "identified": [71], "direct": [74], "target": [75], "EZH2,": [77], "the": [78, 147, 150], "underexpression": [79], "which": [81], "leads": [82], "deficient": [84], "activation": [86], "and": [87, 100, 128], "downstream": [88], "CXCL10/11": [89], "expression": [90, 148], "response": [92], "treatment.": [95, 167], "Dual": [96], "inhibition": [97], "EZH2": [99], "histone": [101, 117], "deacetylase": [102], "(HDAC)": [103], "significantly": [104], "activates": [105], "IFI16-dependent": [106], "immune": [107], "trastuzumab.": [110], "Notably,": [111], "combination": [113], "novel": [116], "methylation": [118], "inhibitor": [119, 123], "an": [121, 142], "HDAC": [122], "induces": [124], "complete": [125], "tumor": [126], "eradication": [127], "long-term": [129], "T": [130], "cell": [131], "memory": [132], "mouse": [137], "model.": [138], "Our": [139], "findings": [140], "demonstrate": [141], "epigenetic": [143], "regulatory": [144], "mechanism": [145], "suppressing": [146], "IFI16-CXCL10/11": [151], "pathway": [153], "provides": [155], "advantage": [158], "confer": [163]}